AbbVie is a pharmaceutical company with a focus on immunology, oncology, neuroscience, and aesthetics. The company's third-quarter earnings were down materially year over year, but it raised its ...

Botox has become so synonymous with anti-aging wrinkle treatments that many people use the name the same way they refer to tissues as Kleenex. But the brand power has a downside: Competitors have ...

Hi! It’s Madison in New York, where I learned the Botox I’ve been injecting into my forehead for the past two years isn’t Botox at all. More on in a bit, but first ... My story starts two years ago, ...

Early this fall a group of influencers, plastic surgeons, at least one Real Housewife and Andy Cohen piled into an underground jazz club in New York City for an event called “Naturally You.” It was ...

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. AbbVie is ending a decade-long partnership with ...

Oct 31 (Reuters) - AbbVie (ABBV.N), opens new tab said on Friday the Trump administration was pushing for steeper cuts in this year's Medicare drug price negotiations, which in 2024 yielded discounts ...

AbbVie Inc. (NYSE:ABBV) reported third-quarter 2025 sales of $15.78 billion on Friday, beating the consensus of $15.59 billion. Sales increased 9.1% on a reported basis or 8.4% on an operational basis ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie raised its earnings guidance for 2025 and added to ...

AbbVie has scrapped an asset from its ongoing collaboration with Dragonfly Therapeutics, a spokesperson for the Chicago pharma confirmed to Fierce Biotech. “We have terminated clinical activity around ...

AbbVie (NYSE:ABBV) announced that its mid-stage study of Botox (onabotulinumtoxinA) for treating essential tremor in the upper limbs achieved its main goal. The research successfully reached its ...